Received May 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945656 | IM / LA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | LG5575 | IM / RA |
Pharmacist did not review records before administering vaccine to patient despite printing the form(s) out. HEPLISAV-B was administered on 01/07/2025 instead of the TWINRIX that he was originally receiving. This incident was repeated again on 2/11/2025 by pharmacist. As a result, the patient did not complete his original TWINRIX vaccination schedule and had to be scheduled to complete 2 doses of HAVRIX in order to have immunity for both hepatitis A and B.
Unknown
Unknown
Heplisav B 20 mcg/0.5 mL injection, Prevnar 20 0.5 mL injection, gabapentin oral capsule 100 mg
NKDA
N/A